Multiple Sclerosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 55 years old (inclusive)
- You have been diagnosed with relapsing-remitting multiple sclerosis (RRMS) based on specific standard diagnostic guidelines
- Your level of disability, as measured by a standard MS scoring tool, is at or below a certain level (confirm with trial site)
- You are either taking one of two specific MS medications (teriflunomide or dimethyl fumarate) at a stable dose for at least 24 weeks, or you have chosen not to take any MS medication after discussing the options with your doctor
- Your doctor does not expect your MS medication to need changing during the study
- Your most recent MRI scan showed no more than two new lesions in your brain or spine
- If you are a woman who could become pregnant, you must have a negative pregnancy test before starting the study
- If you are a woman who could become pregnant, you must agree to use reliable contraception throughout the treatment period
- You are able and willing to follow the study schedule and requirements
- You are willing to sign a consent form agreeing to take part in the study
Who may not be able to join:
- You had an MS relapse in the month before enrolling
- Your MRI scan before the study start shows signs of new disease activity
- You used steroid medications (corticosteroids) in the month before enrolling
- You took antibiotics in the three months before enrolling
- You have been taking any symbiotic, probiotic, prebiotic, or postbiotic supplements in the three months before enrolling
- You have any type of bowel or digestive disease
- You are currently pregnant, breastfeeding, or planning to become pregnant during the study
- You are post-menopausal
- You are a smoker
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Increase in the percentage of Treg cells
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.